Tatva Chintan Pharma Chem IPO

 

Established in Ankleshwar in the year 1996, “Tatwa Chintan Pharma Chem Pvt. Ltd ”is noted as a notable manufacturer and supplier of a broad assortment of hydroxides, specialty chemicals, methylating agents, electrolyte chemicals, pyridinium salts and many more. Tatva Chintan Pharma Chem IPO will hit the market in 16 July 2021.

About Company

They are a private limited firm, acting as a leading organization in this domain since its inception. These chemicals are processed using superior quality compounds and the latest technology under the direction of experienced chemical experts.

The chemicals offered are highly demanding for their characteristics such as longer shelf life, precise formulation, moisture-proof packaging, etc. They offer these chemicals in several packaging options to meet the exact needs of their reputed clients.

Due to their ethical business policies, client oriented approach and competitive pricing structure; they are continuously expanding their market share.

Plant

They have developed a state-of-the-art art infrastructure unit spread over a vast area of ​​land. To complete the smooth and orderly work flow, they have divided they infrastructure into several sub-parts such as procurement, processing, packaging, quality testing, research and development and so on.

They processing unit is equipped with modern machinery based on modern technologies. They infrastructural unit provides us the facility to meet the vast and urgent needs of our patrons within the committed time period.

Management Team

In addition, the components they use in processing are prepared under the guidance of their experienced procurement officers. Works in close coordination with each other, their experts are highly enthusiastic and committed to the growth of our firm.

They are working under the guidance of their mentor “Shekhar Somani”. He have inspired them to work according to the norms and standards of the industry. Their strength lies in: customers, innovation, integrity, people and performance.

Mission

Their mission is to keep clients at the heart of everything they do, and this is achieved through client focus, personal and organizational leadership, and a process of excellence.

Tatva Chintan Pharma Chem IPO Issue

Tatva Chintan Pharma, headquartered in Gujarat has submitted Draft Red Herring Prospectus(DRHP) to Securities and Exchange Board of India(SEBI) for initial public offering (IPO) of INR 450 crore on 31 March, 2021.

They planned to collect INR 450 cr via its initial public offering (IPO).  There is a fresh issue of 225 cr. and offer for sale is around 225 cr. vaule Equity Shares mentioned in the drhp of the company.

They got approval from Securities and Exchange Board of India(SEBI) on 05 July, 2021 to float the initial public offering (IPO) in the market.

Financials Trends

Particulars	For the year/period ended ( in Cr.)
	31-Dec-20	31-Mar-20	31-Mar-19	31-Mar-18
Total Assets	275.99	248.94	187.51	143.72
Total Revenue	195.03	264.62	206.80	137.29
Profit After Tax	31.14	37.79	20.54	12.29

Basic and Diluted Earnings Per Share (EPS)

Financial Period	Basic EPS (in INR)	Diluted EPS (in INR)	Weight
Financial Year 2020	18.81	18.81	3
Financial Year 2019	10.23	10.23	2
Financial Year 2018	6.12	6.12	1
Weighted Average	13.84	13.84
(9 months) Dec. 31, 2020	15.50	15.50	–

Objects of the Issue

• Prepayment / repayment of all or a portion of the outstanding borrowings of the company to be availed on consolidated basis.
• To meet common corporate objectives.

Basis of the offer

The following are some of the qualitative considerations and our strengths that go into determining the Offer Price:

• With constant quality, we are a major supplier of structure guiding agents and phase transfer catalysts.
• With a strong client base across multiple industries and significant entry barriers, the company has a global presence.
• A wide specialised product portfolio that demands a high level of technical expertise
• Advanced production facilities with a priority on chemical methods that are “green.”
• R&D capabilities are robust.
• Promoters with deep knowledge and a solid management team.
• Excellent financial results.

Tatva Chintan Pharma Chem IPO Peer Comparison

S. No.	Company Name	PE
1	Aarti Industries Limited	41.85
2	Navin Fluorine International limited	30.91
3	Alkyl Amines chemicals limited	59.29
4	Vinati Organics Limited	44.11
5	Fine Organic Industries Limited	41.72

IPO Tentative Details

IPO Opening Date	16 July 2021
IPO Closing Date	20 July 2021
Issue Type	Book Built
Face Value	10 per  share
IPO Price	1073 to 1083 per equity share
Market Lot	13
Min Order Quantity	13
Listing At	BSE, NSE
Issue Size	450 cr.
Fresh Issue	225 cr.
Offer for Sale	225 cr.

IPO Tentative Date

Tatva Chintan Pharma Chem IPO open date is 16 July 2021, and the closing date is 20 July 2021. The issue may list on 29 July 2021.

IPO Open Date	16 July 2021
IPO Close Date	20 July 2021
Basis of Allotment Date	26 July 2021
Initiation of Refunds	27 July 2021
Credit of Shares to Demat Account	28 July 2021
IPO Listing Date	29 July 2021

Basis of Allotment

Type	% of Offer	Basis of Allotment
Qualified Institutional Buyer	50	Roughly  equivalent
Non Institutional Investor	15	Roughly  equivalent
Retail	35	Minimum level of 1 lot, based on availability, for every shareholder.

Tatva Chintan IPO Allotment Status

Allotment of equity stocks subject to the Fresh Issue and transfer of the Promoter Selling Shareholders’ OFS Stocks to the winning Bidders subject to the Offer for Sale. Nevertheless, the status of the allotment has yet to be revealed.

Here, you can find the Allotment Status of Tatva Chintan IPO.

Tatva Chintan IPO gmp (Tatva Chintan Pharma Chem IPO gmp)

Tatva Chintan IPO Grey market premium is as follows and you can check GMP of other IPOs as well from links given below:

Date	GMP (in Rs)	Subject to Sauda	Kostak (in Rs)
28 July 2021	1100	4500	550
27 July 2021	1175	2500	250
26 July 2021	1075	4200	450
25 July 2021	999	3600	550
24 July 2021	995	3300	400
23 July 2021	985	2700	300
22 July 2021	965	2900	350
21 July 2021	920	5500	700
20 July 2021	765	4200	650
19 July 2021	738	3200	450
18 July 2021	725	1800	250
17 July 2021	705	4500	500
16 July 2021	658	3500	550
15 July 2021	633	2800	400
14 July 2021	589	2500	350
13 July 2021	605
12 July 2021	595
11 July 2021	590
10 July 2021	580

Check Out The GMP Of other IPOs

• Glenmark Life Sciences IPO
• Rolex Rings IPO
• Nuvoco Vistas IPO

Tatva Chintan Pharma Chem IPO Review

You can apply for Listing gain & long Term as well without any issues. There is great possibilities of growth in their industry.  

Tatva Chintan IPO Risk

• The continued impact of the COVID-19 epidemic might have a substantial influence on their operations, as well as their company and income.
• Manufacturing operations that experience unplanned slowdowns or shutdowns might have a negative impact on their company and financial situation.
• Their institutional customers hold us to high quality standards, technical specifications, and audits. Their reputation might be harmed if they do not meet the quality requirements and technological specifications.
• An increase in the cost of raw materials might have a significant negative impact on their operating performance and financial position.

Other Threats

• Their buisness exposes them to dangers in a number of nations that might have a significant negative impact on their business and prospects.
• Their management has complete control over how the revenues of the Offer are used. Any change in how their Net Proceeds are used would be subject to various regulatory requirements, including shareholder approval.
• For some raw materials, they rely on a small number of suppliers. The loss of one or more of these suppliers might have a negative impact on their business and operations.
• Their production plants are located in a single location, and any negative developments in that region might have a negative impact on their company and operating performance.

Tatva Chintan Pharma Chem IPO Brokerage views

• Yes Securities : Subscribe
• Choice Brokering: Subscribe
• Axis Securities: Subscribe
• IIFL Securities: Subscribe
• Trade swift: Subscribe
• Anand Rathi : Subscribe
• ICICI Securities: Subscribe

Tatva Chintan Pharma Chem IPO Subscription Status

Date	Day	QIB	NII	Retail	Employees	Total Subscription
16 July 2021	1	0.51	1.15	8.32	N/A	4.55
19 July 2021	2	1.98	12.32	23.96	N/A	15.19
20 July 2021	3	187	517	35.68	N/A	182

Promoters

• Ajaykumar Mansukhalal Patel
• Chintan Nitinkumar Shah
• Shekhar Rasiklal Somani

Promoter Holding

Pre Issue Share Holding	81.08%
Post Issue Share Holding